Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epigenetic upregulation of SSTR2 in SSTR2-negative neuroendocrine tumors
NL-OMON23147Recruiting
- Sponsor
- Erasmus MC
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of valproic acid and hydralazine in apudoma (NET), sponsored by Erasmus MC. Started May 2019; status: recruiting.
02
Drugs
valproic acidhydralazine
03
Conditions
apudoma (NET)
Beyond the preview
Go deeper on NL-OMON23147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23147.